PortfoliosLab logoPortfoliosLab logo
PVLA vs. TLSA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PVLA vs. TLSA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Palvella Therapeutics, Inc (PVLA) and Tiziana Life Sciences PLC (TLSA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PVLA achieves a 10.27% return, which is significantly higher than TLSA's -20.81% return.


PVLA

1D
10.27%
1M
-9.55%
YTD
10.27%
6M
25.58%
1Y
372.26%
3Y*
5Y*
10Y*

TLSA

1D
-13.24%
1M
-15.11%
YTD
-20.81%
6M
-30.18%
1Y
-16.90%
3Y*
4.64%
5Y*
-12.87%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PVLA vs. TLSA - Yearly Performance Comparison


2026 (YTD)20252024
PVLA
Palvella Therapeutics, Inc
10.27%772.25%-6.47%
TLSA
Tiziana Life Sciences PLC
-20.81%114.02%-25.09%

Correlation

The correlation between PVLA and TLSA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2024

0.18

Fundamentals

Market Cap

PVLA:

$1.30B

TLSA:

$70.17M

EPS

PVLA:

-$3.75

TLSA:

-$0.59

PB Ratio

PVLA:

46.41

TLSA:

1.35K

Total Revenue (TTM)

PVLA:

$0.00

TLSA:

$0.00

Gross Profit (TTM)

PVLA:

$0.00

TLSA:

-$421.00K

EBITDA (TTM)

PVLA:

-$14.75M

TLSA:

-$42.26M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PVLA vs. TLSA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PVLA
PVLA Risk / Return Rank: 9696
Overall Rank
PVLA Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
PVLA Sortino Ratio Rank: 9595
Sortino Ratio Rank
PVLA Omega Ratio Rank: 9292
Omega Ratio Rank
PVLA Calmar Ratio Rank: 9898
Calmar Ratio Rank
PVLA Martin Ratio Rank: 9797
Martin Ratio Rank

TLSA
TLSA Risk / Return Rank: 3333
Overall Rank
TLSA Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
TLSA Sortino Ratio Rank: 3636
Sortino Ratio Rank
TLSA Omega Ratio Rank: 3535
Omega Ratio Rank
TLSA Calmar Ratio Rank: 3131
Calmar Ratio Rank
TLSA Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PVLA vs. TLSA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Palvella Therapeutics, Inc (PVLA) and Tiziana Life Sciences PLC (TLSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PVLATLSADifference

Sharpe ratio

Return per unit of total volatility

4.57

-0.21

+4.79

Sortino ratio

Return per unit of downside risk

4.12

0.25

+3.88

Omega ratio

Gain probability vs. loss probability

1.49

1.03

+0.46

Calmar ratio

Return relative to maximum drawdown

12.54

-0.31

+12.85

Martin ratio

Return relative to average drawdown

28.59

-0.50

+29.08

PVLA vs. TLSA - Sharpe Ratio Comparison

The current PVLA Sharpe Ratio is 4.57, which is higher than the TLSA Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of PVLA and TLSA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PVLATLSADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.57

-0.21

+4.79

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

4.30

-0.04

+4.34

Drawdowns

PVLA vs. TLSA - Drawdown Comparison

The maximum PVLA drawdown since its inception was -31.48%, smaller than the maximum TLSA drawdown of -94.03%. Use the drawdown chart below to compare losses from any high point for PVLA and TLSA.


Loading charts...

Drawdown Indicators


PVLATLSADifference

Max Drawdown

Largest peak-to-trough decline

-31.48%

-94.03%

+62.55%

Max Drawdown (1Y)

Largest decline over 1 year

-29.93%

-54.00%

+24.07%

Max Drawdown (3Y)

Largest decline over 3 years

-55.66%

Max Drawdown (5Y)

Largest decline over 5 years

-84.02%

Current Drawdown

Current decline from peak

-22.19%

-83.12%

+60.93%

Average Drawdown

Average peak-to-trough decline

-10.66%

-70.29%

+59.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.10%

34.09%

-20.99%

Volatility

PVLA vs. TLSA - Volatility Comparison

The current volatility for Palvella Therapeutics, Inc (PVLA) is 24.98%, while Tiziana Life Sciences PLC (TLSA) has a volatility of 26.73%. This indicates that PVLA experiences smaller price fluctuations and is considered to be less risky than TLSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PVLATLSADifference

Volatility (1M)

Calculated over the trailing 1-month period

24.98%

26.73%

-1.75%

Volatility (6M)

Calculated over the trailing 6-month period

62.87%

54.90%

+7.97%

Volatility (1Y)

Calculated over the trailing 1-year period

82.14%

79.45%

+2.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

82.90%

92.71%

-9.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.90%

112.60%

-29.70%

Dividends

PVLA vs. TLSA - Dividend Comparison

Neither PVLA nor TLSA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PVLA vs. TLSA - Financials Comparison

This section allows you to compare key financial metrics between Palvella Therapeutics, Inc and Tiziana Life Sciences PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00MJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(PVLA) Total Revenue
(TLSA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PVLA and TLSA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TLSA has higher volatility (26.73%) compared to PVLA (24.98%). In terms of maximum drawdown, PVLA dropped -31.48% vs TLSA's -94.03%.

PVLA currently has the higher Sharpe Ratio (4.57 vs -0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PVLA and TLSA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer